» Articles » PMID: 32903645

Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease

Overview
Journal Front Neurosci
Date 2020 Sep 9
PMID 32903645
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is characterized by the aberrant deposition of protein in the brain and is the leading cause of dementia worldwide. Increasingly, there have been reports of the presence of these protein hallmarks in the retina. In this study, we assayed the retina of 5xFAD mice, a transgenic model of amyloid deposition known to exhibit dementia-like symptoms with age. Using OCT, we found that the retinal nerve fiber layer was thinner in 5xFAD at 6, 12, and 17 months of age compared with wild-type littermates, but the inner plexiform layer was thicker at 6 months old. Retinal function showed reduced ganglion cell responses to light in 5xFAD at 6, 12, and 17 months of age. This functional loss was observed in the outer retina at 17 months of age but not in younger mice. We showed using immunohistochemistry and ELISA that soluble and insoluble amyloid was present in the retina and brain at all ages. In conclusion, we report that amyloid is present in brain and retina of 5xFAD mice and that the pattern of neuronal dysfunction occurs in the inner retina at the early ages and progresses to encompass the outer retina with age. This implies that the inner retina is more sensitive to amyloid changes in early disease and that the outer retina is also affected with disease progression.

Citing Articles

Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease.

McCool S, Smith J, Sladek A, Fan S, Van Hook M PLoS One. 2025; 20(3):e0319397.

PMID: 40029927 PMC: 11875347. DOI: 10.1371/journal.pone.0319397.


Hyperhomocysteinemia-induced VCID results in visual deficits, reduced neuroinflammation and vascular alterations in the retina.

Weekman E, Rogers C, Sudduth T, Wilcock D J Neuroinflammation. 2025; 22(1):23.

PMID: 39885592 PMC: 11783940. DOI: 10.1186/s12974-025-03332-7.


The Impact of High-Dose Fish Oil Supplementation on Mfsd2a, Aqp4, and Amyloid-β Expression in Retinal Blood Vessels of 5xFAD Alzheimer's Mouse Model.

Jovanovic Macura I, Milanovic D, Tesic V, Major T, Perovic M, Adzic M Int J Mol Sci. 2024; 25(17).

PMID: 39273347 PMC: 11394872. DOI: 10.3390/ijms25179400.


Age-Related Retinal Layer Thickness Changes Measured by OCT in Mice: Implications for Alzheimer's Disease.

Sanchez-Puebla L, de Hoz R, Salobrar-Garcia E, Arias-Vazquez A, Gonzalez-Jimenez M, Ramirez A Int J Mol Sci. 2024; 25(15).

PMID: 39125789 PMC: 11312090. DOI: 10.3390/ijms25158221.


Biomarker evidence of early vision and rod energy-linked pathophysiology benefits from very low dose DMSO in 5xFAD mice.

Berkowitz B, Paruchuri A, Stanek J, Abdul-Nabi M, Podolsky R, Bustos A Acta Neuropathol Commun. 2024; 12(1):85.

PMID: 38822433 PMC: 11140992. DOI: 10.1186/s40478-024-01799-8.


References
1.
Alexandrov P, Pogue A, Bhattacharjee S, Lukiw W . Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport. 2011; 22(12):623-7. PMC: 3719862. DOI: 10.1097/WNR.0b013e3283497334. View

2.
Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L . The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model. Neurobiol Aging. 2018; 67:181-188. DOI: 10.1016/j.neurobiolaging.2018.03.017. View

3.
Katz B, Rimmer S, Iragui V, Katzman R . Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?. Ann Neurol. 1989; 26(2):221-5. DOI: 10.1002/ana.410260207. View

4.
Dutescu R, Li Q, Crowston J, Masters C, Baird P, Culvenor J . Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol. 2009; 247(9):1213-21. DOI: 10.1007/s00417-009-1060-3. View

5.
den Haan J, Verbraak F, Visser P, Bouwman F . Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis. Alzheimers Dement (Amst). 2017; 6:162-170. PMC: 5328759. DOI: 10.1016/j.dadm.2016.12.014. View